Synergy Pharmaceuticals buy marge
Start price
08.06.16
/
50%
€9.02
Target price
17.12.18
€12.63
Performance (%)
-99.10%
End price
17.12.18
€0.081
Summary
This prediction ended on 17.12.18 with a price of €0.081. Massive losses of -99.10% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Synergy Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.039% | 0.567% | 12.281% | 14.748% |
| iShares Nasdaq 100 | -4.018% | -5.554% | 23.851% | 36.769% |
| iShares Nikkei 225® | -2.389% | -1.434% | 8.335% | 5.073% |
| iShares S&P 500 | -2.115% | -2.351% | 22.061% | 37.971% |
Comments by marge for this prediction
In the thread Synergy Pharmaceuticals diskutieren
Phase-III-Studie zur Behandlung des Reizdarmsyndroms (IBS) Ende Juni positiv erwartet
The compound also has PDUFA date in late January for the treatment of
Chronic idiopathic constipation which should lead to approval and
Synergy's first commercialized product.
(Vom Mitglied beendet)
Stopped prediction by marge for Synergy Pharmaceuticals
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.72
07.09.17
07.09.17
€8.12
07.02.19
07.02.19
-89.92%
07.02.19
07.02.19
